A perspective on point-of-care tests to detect eosinophilic bronchitis

Journal of Asthma

Volumn 52, Issue 3, 2015, Pages 254-261

  Nair, Parameswaran ^a   Zhang, Qiang ^b   Brennan, John D ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Asthma; Bio active paper; COPDe Nose; Eosinophils; Sputum cell counts

Indexed keywords

ACETONE; ANTIBODY; APTAMER; BILIRUBIN; CHROMOGENIC SUBSTRATE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL GRANULE PROTEIN; EOSINOPHIL PEROXIDASE; EOSINOPHIL PROTEIN X; GLUCOSE; GLUCOSE OXIDASE; GOLD NANOPARTICLE; HEMOGLOBIN; KETONE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PEROXIDASE; PROTEIN; UROBILINOGEN; VOLATILE ORGANIC COMPOUND; EPITOPE; ETHYL 1-(4-OXO-8-ARYL-4,6,7,8-TETRAHYDROIMIDAZO(2,1-C)(1,2,4)TRIAZIN-3-YL)FORMATE; FORMIC ACID DERIVATIVE; TRIAZINE DERIVATIVE;

ARTICLE; BREATH ANALYSIS; BRONCHITIS; CHEMOLUMINESCENCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLORIMETRY; COMBINATORIAL CHEMISTRY; CORTICOSTEROID THERAPY; DIAGNOSTIC KIT; DIAGNOSTIC TEST; DISEASE ACTIVITY; DISEASE SEVERITY; DNA HYBRIDIZATION; DNA SEQUENCE; ELECTROCHEMICAL DETECTION; ELECTROCHEMILUMINESCENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; EOSINOPHILIA; EOSINOPHILIC BRONCHITIS; EXPIRED AIR; GAS CHROMATOGRAPHY; GENETIC ANALYSIS; HUMAN; IMAGE ANALYSIS; IMMUNOASSAY; LABORATORY DIAGNOSIS; LEUKOCYTE; MASS SPECTROMETRY; METABOLOMICS; MICROTITER PLATE ASSAY; NUCLEAR MAGNETIC RESONANCE; PAPER; PATIENT MONITORING; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFLAMMATION; SPUTUM CYTODIAGNOSIS; TEST STRIP; URINALYSIS; CHEMISTRY; HOSPITAL INFORMATION SYSTEM; IMMUNOLOGY; SEVERITY OF ILLNESS INDEX; SPUTUM;

BREATH TESTS; BRONCHITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL PEROXIDASE; EOSINOPHILIA; EPITOPES; FORMATES; HUMANS; NITRIC OXIDE; POINT-OF-CARE SYSTEMS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SPUTUM; TRIAZINES;

EID: 84931077717     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2014.966110     Document Type: Article

References (59)

1. Public Health Agency of Canada. Life and Breath: Respiratory Disease in Canada. http://www.phacaspc.gc.ca/publicat/2007/lbrdcvsmrc/ index-eng.php#tphp [last accessed 29 Sep 2012].
2. Wedzicha JA, Wilkinson T. Impact of chronic obstructive pulmonary disease exacerbations on patients and payers. Proc Am Thorac Soc 2006;3:218-221.
3. Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis 2009;4:337-349.
4. D'silva L, Hassan N, Wang HY, Kjarsgaard M, Efthimiadis A, Hargreave FE, Nair P. Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice. Can Respir J 2011;18: 144-148.
5. Nair P, Pizzichini E, Pizzichini MM, Hussack P, Efthimiadis A, Hargreave FE. Clinical judgement of airway inflammation versus sputum cell counts in patients with asthma. Eur Respir J 2000;15: 486-490.
6. Nair P, Aziz-Ur-Rehman A, Radford K. Therapeutic implications of neutrophilic asthma. Curr Opin Pulm Med 2014, (in press).
7. Jayaram L, Pizzichini MM, Cook RJ, Boulet LP, Lemière C, Pizzichini E, Cartier A, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006;27:483-494.
8. Siva R, Green RH, Brightling CE, Shelley M, Hargadon B, McKenna S, Monteiro W, et al. Eosinophilic airway inflammation and exacerbations of COPD: A randomised controlled trial. Eur RespirJ 2007;29:906-913.
9. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996;154:308-317.
10. Belda J, Leigh R, Nair P, O'Byrne PM, Sears MR, Hargreave FE. Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med 2000;161:475-478.
11. Lougheed MD, Lemiere C, Ducharme FM, Licskai C, Dell SD, Rowe BH, Fitzgerald M, et al. Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J 2012;19:127-164.
12. O'Donnell DE, Aaron S, Bourbeau J, Hernandez P, Marciniuk DD, Balter M, Ford G, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2007 update. Can Respir J 2007;14:5B-32B.
13. D'silva L, Neighbour H, Gafni A, Radford K, Hargreave FE, Nair P. Quantitative sputum cell counts to monitor bronchitis: A qualitative study of physician and patient perspectives. Can Respir J 2013;20: 47-51.
14. Chaboillez S, Dasgupta A, Prince P, Boulet LP, Lemière C. A kit to facilitate and standardize the processing of sputum for measurement of airway inflammation. Can Respir J 2013;20:248-252.
15. Ochkur SI, Kim JD, Protheroe CA, Colbert D, Condjella RM, Bersoux S, Helmers RA, et al. A sensitive high throughput ELISA for human eosinophil peroxidase: A specific assay to quantify eosinophil degranulation from patient-derived sources. J Immunol Methods 2012;384:10-20.
16. Nair P, Ochkur SI, Protheroe C, Radford K, Efthimiadis A, Lee NA, Lee JJ. Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia. Allergy 2013;68: 1177-1184.
17. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, et al; American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184: 602-615.
18. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005;352:2163-2173.
19. Nair P, Kjarsgaard M, Armstrong S, Efthimiadis A, O'Byrne PM, Hargreave FE. Nitric oxide in exhaled breath is poorly correlated to sputum eosinophils in patients with prednisone-dependent asthma. J Allergy Clin Immunol 2010;126:404-406.
20. Powell H, Murphy VE, Taylor DR, Hensley MJ, McCaffery K, Giles W, Clifton VL, et al. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: A double-blind, randomized controlled trial. Lancet 2011;378: 983-990.
21. Fens N, Roldaan AC, van der Schee MP, Boksem RJ, Zwinderman AH, Bei EH, Sterk PJ. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease. Clin Exp Allergy 2011;41:1371-1378.
22. Saude EJ, Skappak CD, Regush S, Cook K, Ben-Zvi A, Becker A, Moqbel R, et al. Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy. J Allergy Clin Immunol 2011;27:757-764.e1-6.
23. Jackwood MW, Yousef NMH, Hilt DA. Further development and use of a molecular serotype identification test for infectious bronchitis virus. Avian Diseases 1997;41:105-110.
24. Haqshenas G, Assasi K, Akrami H. Isolation and molecular characterization of infectious bronchitis virus, isolate Shiraz 3. IBV, by RT-PCR and restriction enzyme analysis. Iranian J Vet Res 2005;6:9-15.
25. Lee CW, Hilt DA, Jackwood MW. Redesign of primer and application of the reverse transcriptase-polymerase chain reaction and restriction fragment length polymorphism test to the DE072 strain of infectious bronchitis virus. Avian Diseases 2000;44: 650-654.
26. Jung JW, Kang HR, Lee HS, Park HW, Cho SH, Min KU, Sohn SW. Expression levels of eosinophil granule protein mRNAs in induced sputum reflect airway hyperresponsiveness and airflow limitation. Tohoku J Exp Med 2014;233:49-56.
27. Ochkur SI, Kim JD, Protheroe CA, Colbert D, Condjella RM, Bersoux S, Helmers RA, et al. A sensitive high throughput ELISA for human eosinophil peroxidase: A specific assay to quantify eosinophil degranulation from patient-derived sources. J Immunol Methods 2012;384:10-20.
28. Reimert CM, Venge P, Kharazmi A, Bendtzen K. Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay. J Immunol Methods 1991;138:285-290.
29. Free AH, Adams EC, Kercher ML, Free HM, Cook MH. Simple specific test for urine glucose. Clin Chem 1957;3:163-167.
30. Hu J, Wang S, Wang L, Li F, Pingguan-Murphy B, Lu TJ, Xu F. Advances in paper-based point-of-care diagnostics. Biosens Bioelectron 2014;54:585-597.
31. Pelton R. Bioactive paper provides a low-cost platform for diagnostics. Trends Anal Chem 2009;28:925-942.
32. Yetisen AK, Akram MS, Lowe CR. Paper-based microfluidic pointof-care diagnostic devices. Lab Chip 2013;13:2210-2251.
33. Hossain SM, Brennan JD. Beta-Galactosidase-based colorimetric paper sensor for determination of heavy metals. Anal Chem 2011; 83:8772-8778.
34. Liu H, Crooks RM. Paper-based electrochemical sensing platform with integral battery and electrochromic read-out. Anal Chem 2012;84:2528-2532.
35. Martinez AW, Phillips ST, Carrilho E, Thomas 3rd SW, Sindi H, Whitesides GM. Simple telemedicine for developing regions: camera phones and paper-based microfluidic devices for realtime, off-site diagnosis. Anal Chem 2008;80:3699-3707.
36. Hossain SM, Luckham RE, Smith AM, Lebert JM, Davies LM, Pelton RH, Filipe CD, Brennan JD. Development of a bioactive paper sensor for detection of neurotoxins using piezoelectric inkjet printing of sol-gel-derived bioinks. Anal Chem 2009;81: 5474-5483.
37. Liu JW, Cao ZH, Lu Y. Functional nucleic acid sensors. Chem Rev 2009;109:1948-1998.
38. Lamond AI, Earnshaw WC. Structure and function in the nucleus. Science 1998;280:547-553.
39. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990;346:818-822.
40. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990;249:505-510.
41. Iliuk AB, Hu LH, Tao WA. Aptamer in bioanalytical applications. Anal Chem 2011;83:4440-4452.
42. Song SP, Wang LH, Li J, Zhao JL, Fan CH. Aptamer-based biosensors, Trends Anal Chem 2008;27:108-117.
43. Zhao WA, Ali MM, Aguirre SD, Brook MA, Li YF. Paper-based bioassays using gold nanoparticle colorimetric probes. Anal Chem 2008;80:8431-8437.
44. Su SX, Ali MM, Filipe CDM, Li YF, Pelton R. Micro-based inks for paper-supported biosensing applications. Biomacromolecules 2008;9:935-941.
45. Hamula CLA, Guthrie JW, Zhang H, Li XF, Le XC. Selection and analytical applications of aptamers. Trac-Trends Anal Chem 2006; 25:681-691.
46. Sefah K, Phillips JA, Xiong XL, Meng L, Van Simaeys D, Chen H, Martin J, Tan WH. Nucleic acid aptamers for biosensors and bioanalytical applications. Analyst 2009;134:1765-1775.
47. Song W, Zhu K, Cao Z, Lau C, Lu J. Hybridization chain reactionbased aptameric system for the highly selective and sensitive detection of protein. Analyst 2012;137:1396-1401.
48. Zhao W, Ali MM, Brook MA, Li Y. Rolling Circle Amplification: New applications in nanotechnology and functional nucleic acid-based bio-detection. Angew Chem Int Ed 2008;47:6330-6337.
49. Liu M, Song JP, Shuang SM, Dong C, Brennan JD, Li YF. A grapheme-based biosensing platform based on the release of DNA probes and rolling circle amplification. ACS Nano 2014;8: 5564-5573.
50. Liu HX, Zhan FF, Liu F, Zhu MJ, Zhou XM, Xing D. Visual and sensitive detection of viable pathogenic bacteria by sensing of RNA markers in gold nanoparticles based paper platform. Biosens Bioelectron 2014;62:38-46.
51. Cheng CM, Martinez AW, Gong JL, Mace CR, Phillips ST, Carrilho E, Mirica KA, et al. Paper-based ELISA. Angew Chem Int Ed 2010;49:4771-4774.
52. Hsu CK, Huang HY, Chen WR, Nishie W, Ujiie H, Natsuga K, Fan ST, et al. Paper-based ELISA for the detection of autoimmune antibodies in body fluid-The case of bullous pemphigoid. Anal Chem 2014;86:4605-4610.
53. Ali MM, Aguirre SD, Xu Y, Filipe CDM, Pelton RH, Li Y. Detection of DNA using bioactive paper strips. Chem Comm 2009; 53:6640-6642.
54. Zhao WA, Chiuman W, Brook MA, Li Y. Simple and rapid colorimetric biosensors based on DNA aptamer and noncrosslinking gold nanoparticle aggregation. Chem Bio Chem 2007;8: 727-731.
55. Liu J, Mazumdar D, Lu Y. A simple and sensitive "Dipstick" test in serum based on lateral flow separation of aptamer-linked nanostructures. Angew Chem Int Ed 2006;45:7955-17599.
56. Fens N, Roldaan AC, van der Schee MP, Boksem RJ, Zwinderman AH, Bei EH, Sterk PJ. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease. Clin Exp Allergy 2011;41:1371-1378.
57. Nair P. Anti-IL5 monoclonal antibody to treat severe eosinophilic asthma. N Engl J Med 2014, (in press).
58. Nair P. What is an "eosinophilic phenotype" of asthma?.J Allergy Clin Immunol 2013;132:81-83.
59. Hastie AT, Moore WC, Li H, Rector BM, Ortega VE, Pascual RM, Peters SP, et al. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. J Allergy Clin Immunol 2013;132:72-80.